News
Press ReleaseFOR IMMEDIATE RELEASE COPAN Group announces the departure of Norman Sharples, Chief Executive Officer of Copan Diagnostics, from the Company he co-founded with Daniele Triva in 1994 and the appointment of Fabrizio Mazzocchi as new CEO and member of…
Read MoreCOPAN Diagnostics is proud to announce the second FDA clearance of Colibrí™, a semi-automated pre-analytical processor that is a complementary part of WASPLab®, COPAN’s full laboratory automation system. Colibrí™ system is an in vitro fully automated specimen workup platform designed…
Read More
Press ReleaseFOR IMMEDIATE RELEASE For over 40 years, COPAN, a global leader in pre-analytics has helped to shape the standard for excellence in Clinical Microbiology with innovative sample collection and transport systems and cutting-edge solutions for laboratory automation and artificial…
Read More
On the heels of recent news of FDA clearance for Colibri™, automated colony picking instrument for identification and antimicrobial susceptibility testing* in clinical Microbiology, today COPAN announced the North American launch of PhenoMATRIX® TAG, colony selection software which automatically chooses…
Read More
COPAN Diagnostics is proud to announce the FDA clearance of Colibri™, an automated processor that is a complementary part of WASPLab®, COPAN’s full laboratory automation system. The COPAN Colibri™ System is an in vitro diagnostic device for use in conjunction with the bioMérieux VITEK® MS or Bruker MALDI Biotyper® CA mass spectrometry systems for automating rapid identification of isolated colonies of Gram-negative and Gram-positive bacteria grown on solid culture media. The Colibri™ system, paired with…
Read More
COPAN announces the resolution of its United States International Trade Commission complaint with respondents Cardinal Health, Inc., Innovative Product Brands, Inc., Innovative Product Brands, Inc., KSL Biomedical, Inc., KSL Diagnostics, Inc., Thomas Scientific, LLC, Vectornate Korea Ltd., Vectornate USA, Inc.,…
Read More
FOR IMMEDIATE RELEASE On Friday, August 27, 2021, the United States International Trade Commission instituted an unfair importation investigation, conducted pursuant to 19 U.S.C. § 1337, against several manufacturers and distributors of imported flocked swabs and products containing the flocked…
Read More
On April 20th, 2021, the U.S. Food and Drug Administration (FDA) recently announced further steps to facilitate the emergency use authorization (EUA) of tests for pooling anterior nasal specimens from asymptomatic individuals in serial testing programs (FDA Announces New Streamlined…
Read More
COPAN Diagnostics, Inc. is excited to announce the North America launch of UniVerse™. UniVerse™ revolutionizes up front sample processing for molecular diagnostics automatically managing accessioning, labeling, vortexing, and aliquoting into various secondary assay tubes or 96-well plates. From the inventors…
Read More
By investing in both Europe and the United States, even during this devastating pandemic, COPAN has managed to increase employment opportunities, while supplying the world with the critical collection and transport systems needed for SARS-CoV-2 testing.
Read More